Australia will continue its review of coronavirus vaccines after a 48-year-old woman's death was likely linked to the inoculation, Health Minister Greg Hunt has said.
On Friday, Australia reported its first fatality from blood clots in a recipient of AstraZeneca's Covid-19 shot. It was the third case of the rare blood clots appearing in people who have been administered the vaccine in the country.
“The government will ask ATAGI (Australian Technical Advisory Group on Immunisation) to ensure continuous review of all of the vaccines in terms of their safety and their efficacy,” Hunt said at a televised briefing.
He said there will be no immediate change to further limit the use of the AstraZeneca vaccine and reiterated that the Pfizer vaccine remains the preferred option for people under the age of 50.
